Comera Life Sciences Holdings, Inc. Common Stock
CMRA
CMRA was delisted on the 16th of November, 2023.
11 hedge funds and large institutions have $103K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
46% less capital invested
Capital invested by funds: $190K → $103K (-$86.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.15K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$13 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$262 |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$103 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $29.2K | – | – | – |
|
2
HighTower Advisors
Chicago,
Illinois
| $23K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $21.5K | – | – | – |
|
4
State Street
Boston,
Massachusetts
| $14.4K | – | – | – |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $9.12K | -$103 | -160 | -0.8% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $3.58K | +$1.15K | +1,796 | +32% |
|
7
Morgan Stanley
New York
| $1.12K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $804 | -$262 | -408 | -20% |
|
|
WAM
9
Wolverine Asset Management
Chicago,
Illinois
| $317 | – | – | – |
|
|
10
Wells Fargo
San Francisco,
California
| $47 | +$13 | +20 | +26% |
|
CMRA Hedge Fund Activity: Q2 2023 in Review
11 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q2 2023, worth a combined $103K — down 46% from $190K a quarter earlier.
Fund positioning in CMRA was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.15K. The largest seller was UBS Group, cutting an estimated $262.
- 11 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $103K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q2 2023, down 46% quarter-over-quarter.
- 0 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q2 2023 and 0 closed out.
- The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $1.15K added.
- The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q2 2023 was UBS Group, an estimated $262 sold.
Based on aggregated 13F filings for Q2 2023.